Lymphovascular Invasion at the Time of Radical Prostatectomy Adversely Impacts Oncological Outcomes.

lymphovascular invasion outcomes research prostate cancer prostate surgery prostatectomy

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
26 Dec 2023
Historique:
received: 07 10 2023
revised: 01 12 2023
accepted: 18 12 2023
medline: 11 1 2024
pubmed: 11 1 2024
entrez: 11 1 2024
Statut: epublish

Résumé

Lymphovascular invasion, whereby tumour cells or cell clusters are identified in the lumen of lymphatic or blood vessels, is thought to be an essential step in disease dissemination. It has been established as an independent negative prognostic indicator in a range of cancers. We therefore aimed to assess the impact of lymphovascular invasion at the time of prostatectomy on oncological outcomes. We performed a multicentre, retrospective cohort study of 3495 men who underwent radical prostatectomy for localised prostate cancer. Only men with negative preoperative staging were included. We assessed the relationship between lymphovascular invasion and adverse pathological features using multivariable logistic regression models. Kaplan-Meier curves and Cox proportional hazard models were created to evaluate the impact of lymphovascular invasion on oncological outcomes. Lymphovascular invasion was identified in 19% (

Identifiants

pubmed: 38201549
pii: cancers16010123
doi: 10.3390/cancers16010123
pii:
doi:

Types de publication

Journal Article

Langues

eng

Auteurs

Niranjan J Sathianathen (NJ)

Department of Urology, The Royal Melbourne Hospital, The University of Melbourne, Melbourne, VIC 3050, Australia.

Marc A Furrer (MA)

Department of Urology, The Royal Melbourne Hospital, The University of Melbourne, Melbourne, VIC 3050, Australia.
Department of Urology, University of Bern, 3010 Bern, Switzerland.
Epworth Healthcare, Melbourne, VIC 3121, Australia.
Department of Urology, Solothurner Spitäler AG, Kantonsspital Olten, 4600 Olten, Switzerland.
Department of Urology, Solothurner Spitäler AG, Bürgerspital Solothurn, 4500 Solothurn, Switzerland.

Clancy J Mulholland (CJ)

Department of Urology, The Royal Melbourne Hospital, The University of Melbourne, Melbourne, VIC 3050, Australia.

Andreas Katsios (A)

Department of Urology, University of Bern, 3010 Bern, Switzerland.

Christopher Soliman (C)

Department of Urology, The Royal Melbourne Hospital, The University of Melbourne, Melbourne, VIC 3050, Australia.
Epworth Healthcare, Melbourne, VIC 3121, Australia.

Nathan Lawrentschuk (N)

Department of Urology, The Royal Melbourne Hospital, The University of Melbourne, Melbourne, VIC 3050, Australia.
Epworth Healthcare, Melbourne, VIC 3121, Australia.

Justin S Peters (JS)

Department of Urology, The Royal Melbourne Hospital, The University of Melbourne, Melbourne, VIC 3050, Australia.
Epworth Healthcare, Melbourne, VIC 3121, Australia.

Homi Zargar (H)

Department of Urology, The Royal Melbourne Hospital, The University of Melbourne, Melbourne, VIC 3050, Australia.
Epworth Healthcare, Melbourne, VIC 3121, Australia.

Anthony J Costello (AJ)

Department of Urology, The Royal Melbourne Hospital, The University of Melbourne, Melbourne, VIC 3050, Australia.
Epworth Healthcare, Melbourne, VIC 3121, Australia.
Australian Prostate Centre, North Melbourne, VIC 3051, Australia.

Christopher M Hovens (CM)

Epworth Healthcare, Melbourne, VIC 3121, Australia.
Australian Prostate Centre, North Melbourne, VIC 3051, Australia.

Conrad Bishop (C)

Epworth Healthcare, Melbourne, VIC 3121, Australia.
Department of Urology, Footscray Hospital Western Health, Melbourne, VIC 3011, Australia.

Ranjit Rao (R)

Department of Urology, The Royal Melbourne Hospital, The University of Melbourne, Melbourne, VIC 3050, Australia.
Epworth Healthcare, Melbourne, VIC 3121, Australia.

Raymond Tong (R)

Department of Urology, The Royal Melbourne Hospital, The University of Melbourne, Melbourne, VIC 3050, Australia.
Epworth Healthcare, Melbourne, VIC 3121, Australia.

Daniel Steiner (D)

Epworth Healthcare, Melbourne, VIC 3121, Australia.

Daniel Moon (D)

Department of Urology, The Royal Melbourne Hospital, The University of Melbourne, Melbourne, VIC 3050, Australia.
Genitourinary Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC 3050, Australia.

Benjamin C Thomas (BC)

Department of Urology, The Royal Melbourne Hospital, The University of Melbourne, Melbourne, VIC 3050, Australia.
Epworth Healthcare, Melbourne, VIC 3121, Australia.
Department of Urology, Solothurner Spitäler AG, Bürgerspital Solothurn, 4500 Solothurn, Switzerland.

Philip Dundee (P)

Department of Urology, The Royal Melbourne Hospital, The University of Melbourne, Melbourne, VIC 3050, Australia.
Epworth Healthcare, Melbourne, VIC 3121, Australia.
Department of Urology, Solothurner Spitäler AG, Bürgerspital Solothurn, 4500 Solothurn, Switzerland.

Jose Antonio Rodriguez Calero (JAR)

Institute of Pathology, University of Bern, 3010 Bern, Switzerland.

George N Thalmann (GN)

Department of Urology, University of Bern, 3010 Bern, Switzerland.

Niall M Corcoran (NM)

Department of Urology, The Royal Melbourne Hospital, The University of Melbourne, Melbourne, VIC 3050, Australia.
Department of Urology, Solothurner Spitäler AG, Bürgerspital Solothurn, 4500 Solothurn, Switzerland.
Australian Prostate Centre, North Melbourne, VIC 3051, Australia.
Victorian Comprehensive Cancer Centre, Melbourne, VIC 3050, Australia.
Department of Surgery, University of Melbourne, Melbourne, VIC 3050, Australia.

Classifications MeSH